Skip to main content

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Introduction

Ethicon Inc. had requested a Pennsylvania State Court Judge Arnold New to exclude 120 Transvaginal Mesh (TVM) lawsuits from Mass tort proceedings, stating that the venue is improper since the plaintiffs do not belong to Pennsylvania.

The Supreme Court's recent decision which allows plaintiffs to file a lawsuit in the jurisdiction where the defendant is headquartered or where the injury has allegedly occurred was the reason for Ethicon to make this move. However, in an order dated May 18, the Judge denied the plea as an “integral portion” of Ethicon Pelvic mesh device was manufactured by Secant Medical Inc., a Pennsylvania-based manufacturer. 

Judge Arnold further clarified,  “since a portion of the manufacturing process of the Gynemesh/Gynemesh PS, Prolene, Prolift, Prosima, TVT, TVT-Exact, TVT-Obturator and TVT-Secur Pelvic mesh medical devices occurs in Pennsylvania, this court’s exercise of specific personal jurisdiction comports with traditional notions of fair play and substantial justice.”

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!